凯捷：2023肿瘤学中的数字疗法报告-推进成果设计和创新模式（中译版）（16页）.pdf

《凯捷：2023肿瘤学中的数字疗法报告-推进成果设计和创新模式（英文版）（16页）.pdf》由会员分享，可在线阅读，更多相关《凯捷：2023肿瘤学中的数字疗法报告-推进成果设计和创新模式（英文版）（16页）.pdf（16页珍藏版）》请在三个皮匠报告上搜索。

1、Advancing outcomes designDIGITALTHERAPEUTICSIN ONCOLOGY22023 Capgemini InventDIGITAL THERAPEUTICS IN ONCOLOGYSETTING THE CONTEXT FROM A CLINICAL PERSPECTIVE The digital health market is flooded with direct-to-consumer health and wellness applications.Digital health is a broad category that includes

2、digital therapeutics(DTx).With the advent of technology and innumerable companies entering the digital health space,it is important to understand the significance of proven clinical efficacy of digital health solutions and to differentiate a DTx from other digital health or wellness solutions.Even t

3、hough the first DTx was launched a decade ago,this subject demands more attention.DTx so far has been largely driven by mental and chronic diseases,but these solutions are now finding a place in oncology practice.Not all but some digital cancer solutions are DTx.Four factors are driving the use of D

4、Tx in oncology:1.The complexity of cancer journeys with stringent protocols and multiple stakeholders involved in cancer treatment,plus the need for regular follow-ups.2.A shift towards remote treatment(oral chemotherapy or cancer care in outpatient settings).3.Offering more personalized cancer care

5、 with increased use of immunotherapies or targeted therapies to mitigate treatment-related issues.4.Focus on holistic care improving patients quality of life,including pain and stress management or psychological support.Digital HealthDigital MedicineDigital Therapeutics(DTx)The DTx landscape is stil

6、l evolving,which requires a careful assessment of pain points that might prevent these offerings from achieving critical mass.From establishing the safety and efficacy of a DTx for use in cancer patients and demonstrating superiority over current standards of care,both in a clinical trial setting an